- Pityriasis rubra pilaris
- Psoriasis
Joel M. Gelfand, MD, MSCE, FAAD
About me
- Director, Psoriasis and Phototherapy Treatment Center
- Director, Center for Clinical Sciences in Dermatology
- James J. Leyden, M.D. Endowed Professor in Clinical Investigation
- Professor of Epidemiology in Biostatistics and Epidemiology
My education and training
- Medical School: Harvard University
- Residency: Mount Sinai Hospital
- Residency: University of Pennsylvania Health System
Spoken languages
Reviews
417 reviews
Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.
Insurance accepted
- Aetna Advantra Cares D-SNP
- Aetna Advantra Credit Value
- Aetna Advantra Eagle HMO
- Aetna Advantra Eagle POS
- Aetna Advantra Premier Plus PPO
- Aetna Advantra Value
- Aetna Advantra Value Plus
- Aetna APCN Plus (Multi-Tier)
- Aetna Better Health Kids (CHIP) - DH Only
- Aetna Flexible Five
- Aetna Freedom Core
- Aetna Gold
- Aetna HMO
- Aetna Philly Prime
- Aetna POS
- Aetna PPO APCN
- Aetna Premier
- Aetna Premier Plus
- Aetna Savings Plus
- Aetna Signature Administrators
- Aetna Student Health Plan PPO
- Aetna Upfront Advantage
- First Health HMO
- First Health POS
- First Health PPO
- Meritain - Aramark (Other)
- Meritain - Aramark (Pennsylvania Premier Medical Plan)
- Americhealth Caritas of PA VIP - LGH Only
- Amerihealth Caritas (Transplant patients only)
- Amerihealth Caritas of PA - LGH Only
- Centivo EPO
- Cigna Healthcare EPO
- Cigna Healthcare HMO
- Cigna Healthcare POS
- Cigna Healthcare PPO
- Claim Watcher (Homestead/ INDECs) Open Access
- Clover Health Choice
- Clover Health Choice Value PPO
- Clover Health Classic HMO
- Clover Health Value
Locations
Penn Medicine hospital privileges
- Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
- Pennsylvania Hospital: Has privileges to treat patients in the hospital.
- Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
Qualifications and experience
- Dermatology
- Advisory Committee Boston University's NIAMS Multidisciplinary Clinical Research Center (P60), National
- American Academy of Dermatology, National
- American Board of Dermatology, National
- American Dermatological Association, National
- American Society for Clinical Investigation, National
- Cancer Center, University of Pennsylvania, Local
- Data Safety Monitoring Board Moonlake (Hidradenitis, Psoriasis), International
- Data Safety Monitoring Board Takeda (psoriasis), International
- Data Safety Monitoring Board Teva (Vitiligo and Celiac Disease), International
- Data Safety Monitoring Board-NeuroDerm, International
- Dermatology Foundation, National
- Global Dermato-Epidemiology Forum, Implementation Task Force (WHARI TF) established by the International League of Dermatological Societies (ILDS), International
- Group for Research and Assessment of Psoriasis and Psoriatic Arthritis, International
- Institute for Translational Medicine and Therapeutics, University of Pennsylvania, Local
- International Psoriasis Council, International
- International Society for Pharmacoepidemiology, International
- Massachusetts Medical Society, National
- Medical Dermatology Society, National
- National Institute of Arthritis, Musculoskeletal and Skin Diseases (NIAMS), National
- National Multiple Sclerosis Society Serially Unified Multicenter Multiple Sclerosis Investigation (SUMMIT), National
- National Psoriasis Foundation, National
- NIH/NIAMS, National
- NIH/NIAMS 2026/10 ZRG1 IIDB-Y (02) M, National
- NIH/NIAMS Selected Member Roundtable about Psoriatic Arthritis, National
- Penn Center for Orphan Disease Research and Therapy, National
- PENN Institute for Immunology, Local
- Pennsylvania Academy of Dermatology and Dermatologic Surgery, Local
- Psoriasis Council Board of Directors, International
- Scientific Director FORWARD psoriasis registry, National
- Society for Investigative Dermatology, National
- The Agency for Healthcare Research and Quality, National
- Recognized annually in Philadelphia Magazine's Top Docs issue from 2019 through 2025
Treatments and conditions
Research
Publications
Yeung H, Wan J, Van Voorhees AS, Callis Duffin K, Kreuger GG, Kalb RE, Weisman JD, Sperber BR, Brod BA, Bebo F, Schleicher SM, Shin DB, Troxel AB, Gelfand JM Patient-reported reasons for the discontinuation of commonly used treatments for moderate to severe psoriasis , J Am Acad Dermatol, 68(1): 2013,64-72
Mehta NN, Torigian DA, Gelfand JM, Saboury B, Alavi A Quantification of atherosclerotic plaque activity and vascular inflammation using [18-F] fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT) , J Vis Exp, 63: 2012,e3777
Azfar AS, Seminara NM, Shin DB, Troxel AB, Margolis DJ, Gelfand JM Increased risk of diabetes mellitus and likelihood of receiving diabetes mellitus treatment in patients with psoriasis , Arch Dermatol, 148(9): 2012,995-1000
Gelfand JM, Wan J, Callis Duffin, K, Krueger GG, Kalb RE, Weisman JD, Sperber BR, Stierstorfer MB, Brod BA, Schleicher SM, Bebo BF, Troxel AB, Shin DB, Steinemann JM, Goldfarb J, Yeung H, Van Voorhees AS Comparative effectiveness of commonly used systemic treatments or phototherapy for moderate to severe plaque psoriasis in the clinical practice setting , Arch Dermatol, 148(4): 2012,487-94
Langan SM, Seminara, NM, Shin, DB, Troxel A, Kimmel SE, Mehta NN, Margolis DJ, Gelfand JM Prevalence of metabolic syndrome in patients with psoriasis: a population-based study in the United Kingdom , J Invest Dermatol, 132(3Pt1): 2012,556-62
Mehta N, Yu YD, Saboury B, Foroughi N, Krishnamoorthy P, Raper A, Baer A, Antigua J, Van Voorhees AS, Torigian DA, Alavi A, Gelfand JM Systemic and vascular inflammation in patients with moderate to severe psoriasis as measured by [18F]-fluorodeoxyglucose positron emission tomography-computed tomography (FDG-PET/CT): a pilot study , Arch Dermatol, 147(9): 2011,1031-9
Dommasch, ED, Abuabara, K, Shin, DB, Nguyen, J, Troxel, AB, Gelfand JM The risk of infection and malignancy with tumor necrosis factor antagonists in adults with psoriatic disease: a systematic review and meta-analysis of randomized controlled trials , J Am Acad Dermatol, 64(6): 2011,1035-50
Mehta NN, Azfar RS, Shin DB, Neimann AL, Troxel AB, Gelfand JM Patients with severe psoriasis are at increased risk of cardiovascular mortality: cohort study using the General Practice Research Database , Eur Heart J, 31(8): 2010,1000-6
Gelfand JM, Dommasch E, Shin DB, Azfar RS, Kurd SK, Wang X, Troxel AB The risk of stroke in patients with psoriasis , J Invest Determatol, 129(10): 2009,2411-8
Gelfand JM, Shin DB, Neimann AL, Wang X, Margolis DJ, Troxel AB The risk of lymphoma in patients with psoriasis , J Invest Dermatol, 126(10): 2006,2194-201